Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription 29.04.2024 3 Biochem Biophys Res Commun 3 BMC Cancer 3 BMC Gastroenterol 2 Br J Surg 2 Dig Dis 10 Dig Dis Sci 1 Eur J Pediatr 4 Gastroenterology 1 Gut 1 J Comput Assist Tomogr 2 J Gastroenterol Hepatol 12 J Hepatol 1 J Pediatr Surg 1 Lancet 7 PLoS One 2 Proc Natl Acad Sci U S A 1 Radiology 1 Semin Liver Dis 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. MAO T, Zhang C, Yang S, Bi Y, et al
   Semaglutide alters gut microbiota and improves NAFLD in db/db mice.
   Biochem Biophys Res Commun. 2024;710:149882.
   PubMed         Abstract available
   
   
2. LIU X, Liu R, Wang Y
   Indole-3-carboxaldehyde alleviates acetaminophen-induced liver injury via inhibition of oxidative stress and apoptosis.
   Biochem Biophys Res Commun. 2024;710:149880.
   PubMed         Abstract available
   
   
3. CHEN F
   Inhibiting Pink1/Parkin-mediated mitophagy enhances the anticancer effects of quercetin in hepatocellular carcinomaf.
   Biochem Biophys Res Commun. 2024;712-713:149899.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. PAN Y, You B, Zhao X, Zhang S, et al
   CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells.
   BMC Cancer. 2024;24:525.
   PubMed         Abstract available
   
   
5. WU S, Zheng Y, Wang L, Liu W, et al
   Differences in influencing mechanism of clinicians' adoption behavior for liver cancer screening technology between the leading and subordinate hospitals within medical consortiums.
   BMC Cancer. 2024;24:514.
   PubMed         Abstract available
   
   
6. WU Y, Li L, Wang L, Zhang S, et al
   m(1)A regulator-mediated methylation modification patterns correlated with autophagy to predict the prognosis of hepatocellular carcinoma.
   BMC Cancer. 2024;24:506.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. HAO X, He H, Tao L, Zhao W, et al
   Waistline to thigh circumference ratio as a predictor of MAFLD: a health care worker study with 2-year follow-up.
   BMC Gastroenterol. 2024;24:144.
   PubMed         Abstract available
   
   
8. WEI M, Lu L, Luo Z, Ma J, et al
   Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs.
   BMC Gastroenterol. 2024;24:142.
   PubMed         Abstract available
   
   
9. XIONG J, Wu Y, Chen D, Zhang Z, et al
   MAFLD with central obesity is associated with increased risk of colorectal adenoma and high-risk adenoma.
   BMC Gastroenterol. 2024;24:138.
   PubMed         Abstract available
   
   

   
   Br J Surg

10. SONG J, Cao L, Ma K, Li J, et al
    Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae099.
    PubMed         Abstract available
    
    
11. KORENBLIK R, Heil J, Smits J, James S, et al
    Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort.
    Br J Surg. 2024;111:znae087.
    PubMed         Abstract available
    
    

    
    Dig Dis

12. TAKI S, Ida Y, Tamai H, Maeshima S, et al
    Lusutrombopag Reduces the Risk of Hemoperitoneum Caused by Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Compared with Platelet Transfusion.
    Dig Dis. 2024 Apr 25. doi: 10.1159/000539006.
    PubMed         Abstract available
    
    
13. MORKUNAS E, Vaitkeviciute E, Inciuraite R, Kupcinskas J, et al
    miRNome profiling analysis reveals novel hepatocellular carcinoma diagnostic, prognostic and treatment-related candidate biomarkers: post-hoc analysis of SORAMIC trial.
    Dig Dis. 2024 Apr 24. doi: 10.1159/000538757.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

14. WEBER S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, et al
    Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08446.
    PubMed         Abstract available
    
    
15. TWOHIG PA, Peeraphatdit TB, Samson K, Schissel M, et al
    A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08445.
    PubMed         Abstract available
    
    
16. MANNING ME, Fricker Z
    Cardiopulmonary Resuscitation Outcomes and Trainee Perception of Code Status Discussions in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08443.
    PubMed         Abstract available
    
    
17. MOON AM, Swier RM, Lane LM, Barritt AS 4th, et al
    Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08442.
    PubMed         Abstract available
    
    
18. ZHANG X, Wang W, Mo S, Sun X, et al
    DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08401.
    PubMed         Abstract available
    
    
19. CHANG ML, Le PH, Chen WT, Chen TD, et al
    Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
    PubMed         Abstract available
    
    
20. HORBAL SR, Belancourt PX, Zhang P, Holcombe SA, et al
    Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08450.
    PubMed         Abstract available
    
    
21. HSIEH HC, Chang WP, Huang PJ, Wang CH, et al
    Effectiveness of Exercise Interventions on Body Composition, Exercise Capacity, Fatigue, and Quality of Life in Patients with Liver Cirrhosis: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08447.
    PubMed         Abstract available
    
    
22. MARCANTEI C, Couret A, King J, Mazeaud S, et al
    Effects of Exercise Training on Muscle Mass and Physical Function in Patients with Hepatocellular Carcinoma After Diagnosis: A Systematic Review.
    Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08441.
    PubMed         Abstract available
    
    
23. TAN C, Zeng X, Guo X, Mo M, et al
    A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10.
    Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08383.
    PubMed         Abstract available
    
    

    
    Eur J Pediatr

24. CONTE L, Amodeo I, De Nunzio G, Raffaeli G, et al
    Congenital diaphragmatic hernia: automatic lung and liver MRI segmentation with nnU-Net, reproducibility of pyradiomics features, and a machine learning application for the classification of liver herniation.
    Eur J Pediatr. 2024 Feb 28. doi: 10.1007/s00431-024-05476.
    PubMed         Abstract available
    
    

    
    Gastroenterology

25. NIEMI NM, Debosch BJ
    Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
    Gastroenterology. 2024;166:936-937.
    PubMed        
    
    
26. GEORGE B, Kudryashova O, Kravets A, Thalji S, et al
    Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
    Gastroenterology. 2024;166:859-871.
    PubMed         Abstract available
    
    
27. SCHONAUER R, Sierks D, Boerrigter M, Jawaid T, et al
    Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
    Gastroenterology. 2024;166:902-914.
    PubMed         Abstract available
    
    
28. JIANG C, Lian M, Ma X
    A Rare Case Mimicking Congenital Hepatic Fibrosis.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00483.
    PubMed        
    
    

    
    Gut

29. 
    Correction: Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
    Gut. 2024 Apr 23:gutjnl-2016-312278corr1. doi: 10.1136/gutjnl-2016-312278.
    PubMed        
    
    

    
    J Comput Assist Tomogr

30. PEI J, Wang L, Li H
    Development of a Better Nomogram for Prediction of Preoperative Microvascular Invasion and Postoperative Prognosis in Hepatocellular Carcinoma Patients: A Comparison Study.
    J Comput Assist Tomogr. 2024 Apr 26. doi: 10.1097/RCT.0000000000001618.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

31. 
    Retraction: Rami Al Batran, Fouad Al-Bayaty, Mahmood Ameen Abdulla, Mazen M Jamil Al-Obaidi, Maryam Hajrezaei, Pouya Hassandarvish, Mustafa Fouad, Shahram Golbabapour, Samaneh Talaee. Gastroprotective effects of Corchorus olitorius. J Gastroenterol He
    J Gastroenterol Hepatol. 2024 Apr 26. doi: 10.1111/jgh.16551.
    PubMed        
    
    
32. GRYZIAK M, Kraj L, Stec R
    The role of tumor-associated macrophages in hepatocellular carcinoma-from bench to bedside: A review.
    J Gastroenterol Hepatol. 2024 Apr 23. doi: 10.1111/jgh.16564.
    PubMed         Abstract available
    
    

    
    J Hepatol

33. CIARDULLO S, Perseghin G
    Steatotic liver disease phenotypes in the United States: The impact of alcohol consumption assessment.
    J Hepatol. 2024;80:e203-e204.
    PubMed        
    
    
34. MA D, Li X
    Methodological challenges in studying immune-suppressive neutrophils in HCC models.
    J Hepatol. 2024;80:e215-e216.
    PubMed        
    
    
35. XIAO H, Niu D, Zhang B
    Combined inhibition of Stat3 and periostin synergistically protects mice against liver fibrosis.
    J Hepatol. 2024;80:e207-e209.
    PubMed        
    
    
36. ZHENG C, Wang L, Zou T, Lian S, et al
    Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8+ T cells.
    J Hepatol. 2024 Jan 3:S0168-8278(24)00004-7. doi: 10.1016/j.jhep.2023.
    PubMed         Abstract available
    
    
37. ANDREWS TS, Nakib D, Perciani CT, Ma XZ, et al
    Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
    J Hepatol. 2024;80:730-743.
    PubMed         Abstract available
    
    
38. XIAO MC, Jiang N, Chen LL, Liu F, et al
    TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4alpha stability.
    J Hepatol. 2024;80:778-791.
    PubMed         Abstract available
    
    
39. SUN Z, Liu M, Guo J, Wang S, et al
    BMI status and its changes across adulthood in relation to all-cause mortality in metabolic dysfunction-associated steatotic liver disease.
    J Hepatol. 2024;80:e197-e199.
    PubMed        
    
    
40. WANG Z, Xie D, Li J, Zhai Z, et al
    Molecular force-induced liberation of transforming growth factor-beta remodels the spleen for ectopic liver regeneration.
    J Hepatol. 2024;80:753-763.
    PubMed         Abstract available
    
    
41. YOUNOSSI ZM, Paik JM, Stepanova M, Ong J, et al
    Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
    J Hepatol. 2024;80:694-701.
    PubMed         Abstract available
    
    
42. CHOLANKERIL G, Kanwal F
    Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea".
    J Hepatol. 2024;80:e218-e219.
    PubMed        
    
    
43. XIAO R, Tian Y, Zhang J, Li N, et al
    Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
    J Hepatol. 2024;80:792-804.
    PubMed         Abstract available
    
    
44. FOUAD Y, Ghazinyan H, Alboraie M, Al Khatry M, et al
    Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition.
    J Hepatol. 2024;80:e194-e197.
    PubMed        
    
    

    
    J Pediatr Surg

45. CHENG S, Wang Y, Zhao Y, Wang N, et al
    Targeting GPX4-mediated Ferroptosis Alleviates Liver Steatosis in a Rat Model of Total Parenteral Nutrition.
    J Pediatr Surg. 2024;59:981-991.
    PubMed         Abstract available
    
    

    
    Lancet

46. KARLSEN TH, Rutter H, Carrieri P, Zelber-Sagi S, et al
    The EASL-Lancet Commission on liver health in Europe: prevention, case-finding, and early diagnosis to reduce liver-related mortality.
    Lancet. 2024;403:1522-1524.
    PubMed        
    
    

    
    PLoS One

47. LIU L, Zhang M, Cui N, Liu W, et al
    Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
    PLoS One. 2024;19:e0298004.
    PubMed         Abstract available
    
    
48. LIU XH, Chen HK, Luo J, He XP, et al
    Potassium affects the association between dietary intake of vitamin C and NAFLD among adults in the United States.
    PLoS One. 2024;19:e0295986.
    PubMed         Abstract available
    
    
49. SMITH K, Beach D, Silva R, Balazs G, et al
    Comprehensive analysis of differentially expressed miRNAs in hepatocellular carcinoma: Prognostic, predictive significance and pathway insights.
    PLoS One. 2024;19:e0296198.
    PubMed         Abstract available
    
    
50. SUN J, Yang S, Zhang Y, Xiang W, et al
    Relationship between phthalates exposures and metabolic dysfunction-associated fatty liver disease in United States adults.
    PLoS One. 2024;19:e0301097.
    PubMed         Abstract available
    
    
51. JI Z, Zhang C, Yuan J, He Q, et al
    Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma.
    PLoS One. 2024;19:e0298775.
    PubMed         Abstract available
    
    
52. ADORINI L, Rigbolt K, Feigh M, Roth J, et al
    Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis.
    PLoS One. 2024;19:e0300809.
    PubMed         Abstract available
    
    
53. LI N, Jin S, Wu J, Ji H, et al
    Effect of different treatment modalities on ovarian cancer patients with liver metastases: A retrospective cohort study based on SEER.
    PLoS One. 2024;19:e0299504.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

54. SHERMAN DJ, Liu L, Mamrosh JL, Xie J, et al
    The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
    Proc Natl Acad Sci U S A. 2024;121:e2318619121.
    PubMed         Abstract available
    
    
55. BAKIRI L, Hasenfuss SC, Guio-Carrion A, Thomsen MK, et al
    Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
    Proc Natl Acad Sci U S A. 2024;121:e2404188121.
    PubMed         Abstract available
    
    

    
    Radiology

56. GHOSH A
    B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
    Radiology. 2024;311:e240868.
    PubMed        
    
    

    
    Semin Liver Dis

57. SAVIANO A, Roehlen N, Baumert TF
    Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Semin Liver Dis. 2024 Apr 22. doi: 10.1055/s-0044-1785646.
    PubMed         Abstract available
    
    

    
    Transplantation

58. SNEIDERS D, van Dijk ARM, Darwish-Murad S, van Rosmalen M, et al
    Quantifying the Disadvantage of Small Recipient Size on the Liver Transplantation Waitlist, a Longitudinal Analysis Within the Eurotransplant Region.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004804.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.